CIK 1674712
Vivo Capital, LLC
Institutional 13F holdings & portfolio
Holdings
47
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1–47 of 47
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| TERN | Terns Pharmaceuticals Inc | 5.3M | $1M+ | SH |
| CDTX | Cidara Therapeutics, Inc. | 957K | $1M+ | SH |
| PRAX | Praxis Precision Medicines | 329K | $1M+ | SH |
| COGT | Cogent Biosciences Inc | 2.4M | $1M+ | SH |
| TRVI | Trevi Therapeutics Inc | 5.1M | $1M+ | SH |
| AVDL | Avadel Pharmaceuticals PLC | 2.7M | $1M+ | SH |
| CMPX | Compass Therapeutics Inc | 9.5M | $1M+ | SH |
| DYN | Dyne Therapeutics Inc | 2.6M | $1M+ | SH |
| ABVX | Abivax SA - ADR | 359K | $1M+ | SH |
| DBVT | DBV Technologies SA | 2.5M | $1M+ | SH |
| SABS | SAB Biotherapeutics Inc | 11.4M | $1M+ | SH |
| SLNO | Soleno Therapeutics Inc | 895K | $1M+ | SH |
| DRUG | Bright Minds Biosciences Inc | 502K | $1M+ | SH |
| SVA | Sinovac Biotech Ltd. | 5.9M | $1M+ | SH |
| GERN | Geron Corp | 27.2M | $1M+ | SH |
| ERAS | Erasca Inc | 9.3M | $1M+ | SH |
| ZBIO | Zenas Biopharma Inc | 853K | $1M+ | SH |
| VRDN | Viridian Therapeutics Inc | 983K | $1M+ | SH |
| ACRS | Aclaris Therapeutics, Inc. | 8.9M | $1M+ | SH |
| CAMP | CAMP4 Therapeutics Inc | 4.2M | $1M+ | SH |
| TNGX | Tango Therapeutics Inc | 2.2M | $1M+ | SH |
| ANRO | Alto Neuroscience Inc | 1.0M | $1M+ | SH |
| LBRX | LB Pharmaceuticals Inc | 800K | $1M+ | SH |
| NERV | Minerva Neurosciences Inc | 4.3M | $1M+ | SH |
| ORIC | Oric Pharmaceuticals Inc | 2.1M | $1M+ | SH |
| CRVS | Corvus Pharmaceuticals Holdings | 2.2M | $1M+ | SH |
| OLMA | Olema Pharmaceuticals Inc | 672K | $1M+ | SH |
| PEPG | Pepgen Inc | 2.3M | $1M+ | SH |
| DSGN | Design Therapeutics Inc | 1.6M | $1M+ | SH |
| DNTH | Dianthus Therapeutics Inc | 354K | $1M+ | SH |
| MLTX | Moonlake Immunotherapeutics | 1.0M | $1M+ | SH |
| CTMX | Cytomx Therapeutics Inc | 2.9M | $1M+ | SH |
| UNCY | Unicycive Therapeutics | 1.8M | $1M+ | SH |
| EPRX | Eupraxia Pharmaceuticals Inc | 1.4M | $1M+ | SH |
| ABEO | Abeona Therapeutics, Inc. | 1.8M | $1M+ | SH |
| VSTM | Verastem Inc | 1.1M | $1M+ | SH |
| SLN | Silence Therapeutics PLC | 1.1M | $1M+ | SH |
| MNPR | Monopar Therapeutics Inc | 91K | $1M+ | SH |
| SRZN | Surrozen Inc | 260K | $1M+ | SH |
| PALI | Palisade Bio Inc | 2.3M | $1M+ | SH |
| SERA | Sera Prognostics Inc | 1.7M | $1M+ | SH |
| TIL | Instil Bio Inc | 293K | $1M+ | SH |
| KTTA | Pasithea Therapeutics Corp | 2.1M | $1M+ | SH |
| TENX | Tenax Therapeutics Inc | 208K | $1M+ | SH |
| ENGNW | EnGene Holdings Inc | 285K | $500K+ | SH |
| BOLT | Bolt Therapeutics Inc | 72K | $100K–$500K | SH |
| DTIL | Precision Biosciences Inc | 5K | $15K–$50K | SH |